Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (19070)	2/24/1999 10:32:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

Kahuna, I won't debate with you whether or not Vasoscam will get FDA approval. After all before a drug gets FDA approval a drug is supposed to be PROVED SAFE and EFFECTIVE. The FDA allowed fast track approval of Viagra without ever proving safety in the at risk group of ED patients. If the FDA wasn't too concerned about safety, why should they be terribly concerned about efficacy?! Schering's involvement with Zonagen/Vasomax clearly demonstrates just how bad some of the large pharmas want to get a piece of the action in the ED action.